Researchers Work on Getting Intermittent Fasting FDA Approved as Adjunct Cancer Treatment to Improve Long-Term Survival Rates
...one research group is reportedly working on getting intermittent fasting approved by the US Food and Drug Administration (FDA) as an adjunct therapy for cancer patients.
Earlier research has demonstrated that calorie restriction helps extend the lifespan of animals by improving insulin sensitivity and inhibiting the mTOR pathway. Fasting has also been shown to "starve" cancer cells while simultaneously protecting cells from chemotherapy toxicity.
Intermittent fasting—which is easier to comply with—has been found to have very similar effects, and researchers are now looking at using intermittent fasting to augment cancer treatments and improve long-term survival rates.
More here:
Posted by: tamaratornado@yahoo.com
| Reply via web post | • | Reply to sender | • | Reply to group | • | Start a New Topic | • | Messages in this topic (1) |
No comments:
Post a Comment